Delzicol is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Mesalamine.
| Product ID | 68151-5652_258b12d8-819f-41a6-9116-a1a66a7d69be |
| NDC | 68151-5652 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Delzicol |
| Generic Name | Mesalamine |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204412 |
| Labeler Name | Carilion Materials Management |
| Substance Name | MESALAMINE |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2013-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204412 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-03-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| MESALAMINE | 400 mg/1 |
| SPL SET ID: | 3479cbf1-434e-417f-be73-7c75139013f0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-5853 | Delzicol | mesalamine |
| 68151-5652 | Delzicol | Delzicol |
| 50090-3002 | Delzicol | Delzicol |
| 0023-5901 | Asacol HD | mesalamine |
| 0430-0783 | ASACOL HD | mesalamine |
| 0179-0142 | Lialda | mesalamine |
| 0093-5907 | Mesalamine | Mesalamine |
| 0093-9224 | mesalamine | mesalamine |
| 0378-1375 | Mesalamine | mesalamine |
| 0378-9230 | Mesalamine | mesalamine |
| 0472-1915 | Mesalamine | Mesalamine |
| 0037-0066 | Rowasa | mesalamine |
| 0037-0022 | sfRowasa | mesalamine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DELZICOL 85808925 4372504 Live/Registered |
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED 2012-12-21 |